Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer

被引：0
|
作者：
Hiroki Goya
Hiroshi Kuraishi
Shigeru Koyama
Takashi Ichiyama
Fumiaki Yoshiike
Kazuya Hirai
Toshihiko Agatsuma
Kazunari Tateishi
Shintaro Kanda
Hiroshi Yamamoto
Keishi Kubo
Tomonobu Koizumi
机构：
[1] Nagano Red Cross Hospital,Respiratory Division
[2] Nagano Municipal Hospital,Respiratory Division
[3] Shinshu University School of Medicine,First Department of Internal Medicine
[4] Shinshu University Hospital School of Medicine,Division of Clinical Oncology, Comprehensive Cancer Center
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 70卷
关键词：
Chemo-refractory; Salvage chemotherapy; Second line; CTP-11;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 697
页数：6
相关论文
共 50 条
  • [21] A phase II clinical study of using nab-paclitaxel as second-line chemotherapy for Chinese patients with advanced non-small cell lung cancer
    Hu, Wei
    Zhang, Zhiping
    MEDICAL ONCOLOGY, 2015, 32 (06)
  • [22] A phase II clinical study of using nab-paclitaxel as second-line chemotherapy for Chinese patients with advanced non-small cell lung cancer
    Wei Hu
    Zhiping Zhang
    Medical Oncology, 2015, 32
  • [23] A Phase I/II Study of GTI-2040 Plus Docetaxel as Second-Line Treatment in Advanced Non-small Cell Lung Cancer A Study of the PMH Phase II Consortium
    Leighl, Natasha B.
    Laurie, Scott A.
    Chen, Xueyu E.
    Ellis, Peter
    Shepherd, Frances A.
    Knox, Jennifer J.
    Goss, Glenwood
    Burkes, Ronald L.
    Pond, Gregory R.
    Dick, Christopher
    Yun, Yun
    Zwiebel, James A.
    Moore, Malcolm J.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : 1163 - 1169
  • [24] Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study
    Zheng, Yulong
    Fang, Weijia
    Mao, Chenyu
    Qian, Joing
    Zhao, Peng
    Zhang, Xiaochen
    Jiang, Haiping
    Zheng, Yi
    Xu, Nong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) : 503 - 509
  • [25] Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study
    Yulong Zheng
    Weijia Fang
    Chenyu Mao
    Joing Qian
    Peng Zhao
    Xiaochen Zhang
    Haiping Jiang
    Yi Zheng
    Nong Xu
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 503 - 509
  • [26] Pemetrexed single agent in previously treated non-small cell lung cancer: A multi-institutional observational study
    Bearz, Alessandra
    Garassino, Isabella
    Cavina, Raffaele
    Favaretto, Adolfo
    Boccalon, Massimo
    Talamini, Renato
    Berretta, Massimiliano
    Spazzapan, Simon
    Simonelli, Cecilia
    Santoro, Armando
    Tirelli, Umberto
    LUNG CANCER, 2008, 60 (02) : 240 - 245
  • [27] Doublet regimen of cisplatin plus docetaxel for second-line chemotherapy after prior therapy with cisplatin plus irinotecan for non-small cell lung cancer: A phase II study
    Seto T.
    Takezako Y.
    Nakamura H.
    Takeda K.
    Inoue F.
    Semba H.
    Eguchi K.
    International Journal of Clinical Oncology, 2004, 9 (5) : 378 - 382
  • [28] Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer:: a phase II study of the Galician Lung Cancer Group (GGCP 013-02)
    Vazquez, Sergio
    Huidobro, Gerardo
    Amenedo, Margarita
    Firvida, Jose Luis
    Leon, Luis
    Lazaro, Martin
    Grande, Carlos
    Mel, Jose Ramon
    Ramos, Manuel
    Salgado, Mercedes
    Casal, Joaquin
    ANTI-CANCER DRUGS, 2007, 18 (10) : 1201 - 1206
  • [29] Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer
    Song, SY
    Kim, WS
    Kim, K
    Jung, CW
    Im, YH
    Kim, HJ
    Kang, WK
    Lee, HG
    Kwon, OJ
    Rhee, CH
    Park, CH
    Park, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (10) : 509 - 513
  • [30] Phase II study of pemetrexed plus oxaliplatin for platinum-resistant advanced or metastatic non-small cell lung cancer patients
    Lee, Dae Ho
    Choi, Chang-Min
    Kim, Sang-We
    Suh, Cheolwon
    Lee, Jung-Shin
    MEDICAL ONCOLOGY, 2012, 29 (02) : 640 - 643
12345